ACTIVE-INGREDIENT OF L-CARNITINE AMP each 5 ml contains1 mg INDICATION OF L-CARNITINE AMP 1-treatment of primary carnitine deficiency characterised by chronic muscle weakness, recurrent episodes of coma and hypoglycaemia (usually in infants and children ) , encephalopathy , and cardiomyopathy
The convenience of oral tablets may matter to patients who sometimes avoid injectables out of aversion to needles
Watch out for constipation
Final pricing is confirmed by your provider based on your prescribed dose, supply duration, and pharmacy of choice
Jurez-Rojas JG, Reyes-Soffer G, Conlon D, Ginsberg HN
Key take: GLP-1s represent a new frontier, signaling the dawn of real preventive and longevity medicine, but theres still a long road before we see longevity drugs for everyone